Symptoms of depression common in patients with nAMD

Posted on

Patients with nAMD who reported poorer self‐rated health (SRH), reductions in daily living activities, and reduced visual function had increased odds of having depressive symptoms, according to a study.

In this clinic‐based cohort, 547 patients with nAMD who presented for treatment were administered the Centre of Epidemiological Studies Depression 10‐point scale (CES‐D‐10) and Mental Health Index (MHI) component of the 36‐item Short Form Survey; the prevalence of depressive symptoms was 42.04% and 31.78%, respectively.

Poor self‐rated health, impaired activities of daily living, and a visual function score within the 2 lowest quartiles were associated with increased odds of depressive symptoms using both scales.

Van Vu K, Mitchell P, Detaram HD, et al. Prevalence and risk factors for depressive symptoms in patients with neovascular age‐related macular degeneration who present for anti‐VEGF therapy. Acta Ophthalmol. 2020; https://doi.org/10.1111/aos.14635.

Related Articles
Wearable collision warning device helps visually impaired individuals
Jul 22, 2021
Psoriasis linked with significantly higher risk of retinal diseases
Jul 20, 2021
Ranibizumab biosimilar has comparable efficacy, safety profile to reference product in patients with nAMD
Jul 19, 2021